These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10836299)

  • 21. Mannose-6-phosphate/insulin-like growth factor-II receptor expression levels during the progression from normal human mammary tissue to invasive breast carcinomas.
    Berthe ML; Esslimani Sahla M; Roger P; Gleizes M; Lemamy GJ; Brouillet JP; Rochefort H
    Eur J Cancer; 2003 Mar; 39(5):635-42. PubMed ID: 12628843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein.
    Leal CB; Schmitt FC; Bento MJ; Maia NC; Lopes CS
    Cancer; 1995 Apr; 75(8):2123-31. PubMed ID: 7697603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentric mammary carcinoma: evidence of monoclonal proliferation.
    Middleton LP; Vlastos G; Mirza NQ; Eva S; Sahin AA
    Cancer; 2002 Apr; 94(7):1910-6. PubMed ID: 11932891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
    Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions.
    Zagouri F; Sergentanis TN; Nonni A; Papadimitriou CA; Michalopoulos NV; Domeyer P; Theodoropoulos G; Lazaris A; Patsouris E; Zogafos E; Pazaiti A; Zografos GC
    BMC Cancer; 2010 Jul; 10():353. PubMed ID: 20602789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
    Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
    Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular markers and therapeutic targets in ductal carcinoma in situ.
    Boland GP; Knox WF; Bundred NJ
    Microsc Res Tech; 2002 Oct; 59(1):3-11. PubMed ID: 12242692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.
    Ottesen GL; Christensen IJ; Larsen JK; Larsen J; Baldetorp B; Linden T; Hansen B; Andersen J
    Breast Cancer Res Treat; 2000 Apr; 60(3):219-26. PubMed ID: 10930109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Breast cancer: comparison between biochemical and immunohistochemical determination of estrogen receptors].
    Roa JC; Baeza R; Romeo E; Andrade L; Foradori A; González S
    Rev Med Chil; 1996 Mar; 124(3):307-12. PubMed ID: 9008942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK; Nair S
    Int J Mol Med; 2001 Aug; 8(2):193-8. PubMed ID: 11445874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia.
    Gillett CE; Lee AH; Millis RR; Barnes DM
    J Pathol; 1998 Apr; 184(4):396-400. PubMed ID: 9664905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of prostate specific antigen in breast cancer.
    Miller MK; Unger PD; Bleiweiss IJ
    Breast Cancer Res Treat; 2001 Jul; 68(2):111-6. PubMed ID: 11688514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of interleukin-1beta in human breast carcinoma.
    Jin L; Yuan RQ; Fuchs A; Yao Y; Joseph A; Schwall R; Schnitt SJ; Guida A; Hastings HM; Andres J; Turkel G; Polverini PJ; Goldberg ID; Rosen EM
    Cancer; 1997 Aug; 80(3):421-34. PubMed ID: 9241076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
    Allred DC; Clark GM; Molina R; Tandon AK; Schnitt SJ; Gilchrist KW; Osborne CK; Tormey DC; McGuire WL
    Hum Pathol; 1992 Sep; 23(9):974-9. PubMed ID: 1355464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.